SANGAMO THERAPEUTICS INC revenue breakdown overview

SANGAMO THERAPEUTICS INC revenue for the last year amounted to 55.83 M EUR, the most of which — 55.83 M EUR — came from its highest performing source at the moment, Epigenetic, the year earlier bringing 159.67 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SANGAMO THERAPEUTICS INC 55.83 M EUR, and the year before that — 159.67 M EUR.